Akso Health (AHG) Shares Outstanding (Weighted Average) (2017 - 2025)
Akso Health (AHG) reported Shares Outstanding (Weighted Average) of $1767296.9 billion for Q3 2025, up 152.81% on a YoY basis from $699050.8 billion in Q3 2024, and up 206631605.67% quarter-over-quarter from $855.3 million in Q1 2025.
Akso Health (AHG) Shares Outstanding (Weighted Average) (2017 - 2025) Analysis & Trends
Akso Health has reported Shares Outstanding (Weighted Average) for 9 years, with the latest figure at $1767296.9 billion in Q3 2025.
- For the quarter ending Q3 2025, Shares Outstanding (Weighted Average) rose 152.81% year-over-year to $1767296.9 billion; the trailing twelve-month figure through Sep 2025 stood at $1767296.9 billion (up 152.81% YoY), and the FY2025 full-year result was $855.3 million, up 504.37% from the prior year.
- Shares Outstanding (Weighted Average) for Q3 2025 stood at $1767296.9 billion, up from $855.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Weighted Average) was $1767296.9 billion in Q3 2025, with the low at $10000.0 in Q3 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $246634.9 billion across 5 years, with a median of $64.1 million in 2022.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Weighted Average) sank 100.0% — and 2024, when it jumped 1398101591900.0%.
- Akso Health's Shares Outstanding (Weighted Average) stood at $180000.0 in 2021, then sank by 94.44% to $10000.0 in 2022, then soared by 400.0% to $50000.0 in 2023, then jumped by 1398101591900.0% to $699050.8 billion in 2024, then surged by 152.81% to $1767296.9 billion in 2025.
- The last three Shares Outstanding (Weighted Average) figures came in at $1767296.9 billion (Q3 2025), $855.3 million (Q1 2025), and $699050.8 billion (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | 1,767,296.88 Bn |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | 123.60 Mn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | 194.38 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | 235.00 Mn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 114.94 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | 76.43 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | 37.48 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | 24.54 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 47.09 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | 14.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1,767,296.88 Bn |
| Mar 31, 2025 | 855.29 Mn |
| Sep 30, 2024 | 699,050.80 Bn |
| Mar 31, 2024 | 141.52 Mn |
| Sep 30, 2023 | 50,000.00 |
| Mar 31, 2023 | 68.60 Mn |
| Sep 30, 2022 | 10,000.00 |
| Mar 31, 2022 | 59.61 Mn |
| Sep 30, 2021 | 180,000.00 |
| Mar 31, 2021 | 48.84 Mn |
| Sep 30, 2020 | 48,909.53 Bn |
| Mar 31, 2020 | 48.76 Mn |
| Sep 30, 2019 | 48,698.06 Bn |
| Mar 31, 2019 | 48.69 Mn |
| Dec 31, 2018 | 48,937.90 Bn |
| Sep 30, 2018 | 48,728.10 Bn |
| Jun 30, 2018 | 47,999.13 Bn |
| Mar 31, 2018 | 44.98 Mn |
| Dec 31, 2017 | 46,131.96 Bn |
| Sep 30, 2017 | 42,921.60 Bn |